TERT and myxoid liposarcoma: Notably, breakpoint t(12;16) and telomerase reverse transcriptase (TERT) C228T ctDNA levels as assessed with ddPCR correlated with clinical course and tumour burden in 4 patients with myxoid liposarcoma [67].